SUBSCRIBE
SUBSCRIBE
News   Policy

Dr. Reddy’s Laboratories Ltd.'s Gets Preliminary FDA Nod for Asthma Drug

June 9, 2010 | 
1 min read
Reuters -- India's Dr Reddy's Laboratories (REDY.BO) has got tentative approval from U.S. regulators to launch the generic version of AstraZeneca's (AZN.L) Accolate, used to treat asthma, a company spokesman said on Wednesday.
Regulatory
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Wooden blocks with arrow and error icon. Delays and disruptions, stop the process, critical error concept
Neurodegenerative disease
Edgewise Takes a Hit as FDA Blocks Accelerated Path for Becker Muscular Dystrophy Drug
June 27, 2025
 · 
2 min read
 · 
Tristan Manalac
Government
Trump’s CDC Pick Says Vaccines Are Safe, Promises To Keep Them Available
June 26, 2025
 · 
2 min read
 · 
Tristan Manalac
Successful businessman standing in front of multiple pathways, making a decision for the right move. A symbol of great investment and positive progress in the development of business. stock illustration
Mergers & acquisitions
Lilly-Verve Proxy Filing Reveals Tumult After Departure of FDA’s Marks
June 26, 2025
 · 
4 min read
 · 
Annalee Armstrong
Health and Human Services Secretary Robert F. Kennedy Jr. makes remarks at an event announcing the MAHA (Make America Healthy Again) Commission, Thursday, May 22, 2025, in the East Room of the White House. (Official White House Photo by Joyce N. Boghosian)
Vaccines
RFK Cuts U.S. Funding From Vaccine Alliance Gavi, Claims Group ‘Ignored the Science’
June 26, 2025
 · 
2 min read
 · 
Tristan Manalac